StreetAlpha.app
Home › Stocks › ENLV

Enlivex Ltd. (ENLV)

$1.05
▼ −10.26%
LAST CLOSE · NOV 20

Enlivex develops Allocetra, a therapy for knee osteoarthritis, and holds RAIN tokens in its treasury. It last closed at $1.05 on Nov 20, down 10.26% on the day.

AI Auto Pilots
Is ENLV in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ENLV.

Key Stats

Last 12 months
Results
Net income
$1.2B
Balance sheet
Cash & equivalents
$1.9M
At Dec 31
Shareholder equity
$1.9B
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$14.5M−$14.5MFY2021FY2022: −$31.1M−$31.1MFY2022FY2023: −$29.1M−$29.1MFY2023FY2024: −$15.0M−$15.0MFY2024FY2025: $1.2B$1.2BFY2025

From ENLV's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 25). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ENLV
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ENLV

Technical Analysis

ENLV · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 48% below its 20 day and 363% below its 50 day average. It is 11358% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 15), oversold. The nearest support is the 52 week low at $1.00, and the nearest resistance the Pivot at $1.11.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 38.4%/day
Key levels
$434.4052 week high+41271.4%
$120.30200 day average+11357.1%
$26.85100 day average+2457.1%
$6.88Swing high (Oct 8)+555.2%
$4.8650 day average+362.9%
$1.5520 day average+47.6%
$1.16Pivot R1+10.5%
$1.11Pivot+5.7%
$1.05Last close
$1.0052 week low−4.8%
$1.00Swing low (Nov 16)−4.8%
$0.99Pivot S1−5.7%
Indicators
RSI (14)15.44Oversold below 30Oversold
MACD-1.32Above its signal lineBullish
Stochastic14.0Near the bottom of its rangeOversold
ADX (14)66.8Strong downtrend
Williams %R-91.1Oversold below −80, overbought above −20Oversold
CCI (20)-68.6Oversold below −100, overbought above 100Neutral
Rate of change−17.3%Change over 10 sessionsBearish
ATR (14)$0.40Typical daily range, 38.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ENLV

What happened before

See how ENLV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ENLV usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ENLV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2008.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ENLVHow many large options trades hit ENLV, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

ENLV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼17 buying vs 24 selling
  • ▼Shares held by funds -91.1%
  • ▼Funds holding -8
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding1725−32.0%
In funds' top 1000–
Held by funds–––
New / increased17 / 05 / 9+21.4%
Reduced / sold out0 / 247 / 13+20.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ENLV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ENLV is in one of them and how their past ENLV trades turned out.

ENLV in the AI portfolios
Loading…

ENLV News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ENLV in an article yet. Here's the latest on the wider market.

ENLV in the news

About Enlivex

Enlivex is a drug development company based in Tel Aviv. It is developing Allocetra, a therapy designed to rebalance the immune system, and is testing it as a possible treatment for knee osteoarthritis, a joint condition linked to aging. The company also holds a treasury of RAIN, the governance token of a decentralized prediction markets platform built on the Arbitrum network.

Headquarters
Tel Aviv